Journal
BLOOD
Volume 104, Issue 8, Pages 2359-2367Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2004-01-0349
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01 RR00833] Funding Source: Medline
- NHLBI NIH HHS [R01 HL46979] Funding Source: Medline
Ask authors/readers for more resources
von Willebrand disease (VWD) type 1 is difficult to diagnose because of bleeding variability and low heritability of von Willebrand factor (VWF) levels. We compared a bleeding severity score and bleeding times to candidate gene haplotypes within pedigrees of 14 index cases, using a covariance components model for multivariate traits (Mendel: QTL Association). These pedigrees included 13 affected and 40 unaffected relatives, as defined by plasma ristocetin cofactor (VWF:RCo) levels. The bleeding severity score was derived from a detailed history. Donors were genotyped using a primer extension method, and 9 candidate genes were selected for analysis. VWF:RCo levels had the strongest influence on bleeding severity score and bleeding time. ITGA2 haplotype 2 (807C) and ITGA2B haplotype 1 (IIe(843)) were each associated With increased bleeding severity scores (P <.01 and P <.01, respectively). GP6 haplotype b (Pro(219)) was also associated with increased scores (P =.03) after adjustment for donor age. No association was ob-served with 6 other candidate genes, GP1BA, ITGB3, VWF, FGB, IL6, or TXA2R. Increased plasma VWF:Ag levels were associated with VWF haplotype 1 (-1793G; P =.02). These results establish that genetic differences in the adhesion receptor subunits alpha(2), alpha(IIb), and GPVI can influence the phenotype of VWD type 1. (C) 2004 by The American Society of Hematology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available